Jemincare
Clinical trials sponsored by Jemincare, explained in plain language.
-
Can a new pill drain stubborn kidney swelling?
Disease control CompletedThis trial tests an experimental drug called JMKX003142 in people with kidney-related swelling (edema) that doesn't improve with standard diuretics. Participants take the drug or a placebo once daily for seven days. The study measures changes in body weight, urine output, and leg…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New asthma drug JYB1904 shows promise in early trial
Disease control CompletedThis study tested a new drug, JYB1904, in 69 adults with allergic asthma. Participants received either JYB1904 every 8 weeks or the standard drug omalizumab every 2 to 4 weeks for 24 weeks. The goal was to see how the drug behaves in the body, how safe it is, and how well it cont…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for advanced skin cancer: targeted pill tested in china
Disease control CompletedThis study tested a drug called sonidegib in 160 Chinese adults with a type of advanced skin cancer (basal cell carcinoma) that could not be treated with surgery or radiation. The drug is taken as a capsule and works by blocking signals that help cancer grow. The main goal was to…
Phase: PHASE4 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a Five-Day injection drain the fluid that weighs down heart failure patients?
Symptom relief CompletedThis trial tests an experimental injection called JMKX003142 in people with heart failure who have fluid buildup (edema), causing swelling and congestion. Participants receive either the drug or a placebo once daily for five days. The goal is to see if the drug safely reduces exc…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC